Target intelligence / Profile preview

Immunoglobulin heavy variable 1-46 (IGHV1-46)

Target
IGHV1-46
Molecular classification
Immunoglobulin variable region, Other (germline gene segment for antibody variable domain)
01

Overview

Immunoglobulin heavy variable 1-46 (IGHV1-46) is a germline gene segment encoding part of the variable region of the heavy chain of human immunoglobulins (antibodies)[1][3][6]. The IGHV1-46 gene segment is involved in generating antibody diversity through V(D)J recombination during B cell development, contributing to the specificity of antigen binding and the humoral immune response[1][3][6]. Allelic variations in IGHV gene segments can influence the function and binding properties of antibodies and have been associated with variability in immune responses against infections such as SARS-CoV-2[2][4]. IGHV1-46 itself is not a therapeutic target; rather, it is a building block in antibody molecules, which may become therapeutically relevant if incorporated into a monoclonal antibody. IGHV gene usage is also important in studies of vaccine and infection responses but is not typically used directly as a therapeutic or diagnostic target[3][6].

Other names
Immunoglobulin heavy variable 1-46IGHV1-46Ig heavy chain V-I region DOTIg heavy chain V-I region HG3Ig heavy chain V-I region MotIGHV146
02

Biological functions

Antigen bindingImmune response
03

Disease associations

InfectionOther (influence on antibody-mediated immunity and neutralization)

Beyond the preview

Go deeper on Immunoglobulin heavy variable 1-46 (IGHV1-46).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 1-46 (IGHV1-46).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call